NCT00005991View on ClinicalTrials.gov

Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 25, 1997

Primary Completion Date

February 14, 2003

Study Completion Date

February 14, 2003

Conditions
Breast Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (1)

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00005991 - Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter